Sign in

CIK 0001750284

  • Non-accelerated filer
  • Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
300409740
Phone
+1 415-651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-11-18 Horn Kinney Chief Business Officer Grant or award · Stock Option (Right to Buy) +89,670 89,670
2020-11-18 Harmon Cyrus Chief Technology Officer Grant or award · Stock Option (Right to Buy) +179,340 179,340
2020-11-18 CLARK IAN T Director Grant or award · Stock Option (Right to Buy) +21,520 21,520
2020-11-18 BUTITTA CYNTHIA M Director Grant or award · Stock Option (Right to Buy) +21,520 21,520
2020-11-18 Bohen Sean President and CEO Grant or award · Stock Option (Right to Buy) +538,020 538,020
2020-09-30 Graham G. Walmsley Director Purchase · Series C Convertible Preferred Stock +1,183,114 $11.06 $13.1M 1,183,114
2020-09-23 Bohen Sean President and CEO Exercise or conversion +51,649 $4.82 $249K 51,649
2020-09-23 Bohen Sean President and CEO Exercise or conversion · Stock Option (Right to Buy) −51,649 976,316
2020-09-19 Moriarty John B EVP, Ch. Legal Officer & Sec. Grant or award · Stock Option (Right to Buy) +252,060 252,060
2020-09-19 Bohen Sean President and CEO Grant or award · Stock Option (Right to Buy) +82,931 82,931
2020-09-19 Bohen Sean President and CEO Grant or award · Stock Option (Right to Buy) +1,027,965 1,027,965
2020-09-18 RAPPAPORT ANDREW Director Grant or award · Stock Option (Right to Buy) +56,964 56,964
2020-09-18 MCCORMICK FRANK Director Grant or award · Stock Option (Right to Buy) +56,964 56,964
2020-09-16 BUTITTA CYNTHIA M Director Exercise or conversion +83,876 $4.41 $370K 83,876
2020-09-16 BUTITTA CYNTHIA M Director Exercise or conversion · Stock Option (Right to Buy) −83,876 0
2020-09-12 Harmon Cyrus Chief Technology Officer Grant or award · Stock Option (Right to Buy) +227,859 227,859
2020-08-12 CLARK IAN T Director Grant or award · Stock Option (Right to Buy) +209,690 209,690
2020-08-12 BUTITTA CYNTHIA M Director Grant or award · Stock Option (Right to Buy) +83,876 83,876
2020-06-15 Myles David C. Chief Development Officer Grant or award +143,472 591,821
2020-06-15 Kushner Peter J. Chief Scientific Officer Grant or award +143,472 1,072,752

Page 23 of 24 · 465 trades